Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (23)

2023

  1. Recommendations for the integral diagnosis of chronic viral hepatitis in a single analytical extraction

    Gastroenterologia y Hepatologia, Vol. 46, Núm. 2, pp. 150-162

  2. Transmitted drug resistance to antiretroviral drugs in Spain during the period 2019–2021

    Journal of Medical Virology, Vol. 95, Núm. 12

2022

  1. Ten steps to eliminating hepatitis C in hospitals

    Nature Reviews Gastroenterology and Hepatology

2020

  1. The algorithm used for the interpretation of doravirine transmitted drug resistance strongly influences clinical practice and guideline recommendations

    The Journal of antimicrobial chemotherapy, Vol. 75, Núm. 5, pp. 1294-1300

2018

  1. Interspecies transmission of the blaOXA-48 gene from a klebsiella pneumoniae high-risk clone of sequence type 147 to different Escherichia coli clones in the gut microbiota

    Antimicrobial Agents and Chemotherapy

2013

  1. Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies

    AIDS, Vol. 27, Núm. 1, pp. 81-85

2012

  1. Clinical, virological and biochemical evidence supporting the association of HIV-1 reverse transcriptase polymorphism R284K and thymidine analogue resistance mutations M41L, L210W and T215Y in patients failing tenofovir/emtricitabine therapy

    Retrovirology, Vol. 9

2005

  1. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 5, pp. 1965-1972

  2. Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain

    Journal of Clinical Virology, Vol. 33, Núm. 1, pp. 65-70

2004

  1. HIV-2 and HTLV-I/II infections in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, Núm. 3, pp. 177-182

2002

  1. Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]

    Journal of Antimicrobial Chemotherapy

  2. Clinical impact of HTLV-1 infection in Spain: Implications for public health and mandatory screening [3]

    Journal of Acquired Immune Deficiency Syndromes

1998

  1. Genetic analysis of human immunodeficiency virus type 2 strains from spain

    AIDS Research and Human Retroviruses

1996

  1. Epidemiology of HIV-2 infection in Spain

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 15, Núm. 5, pp. 383-388

1995

  1. HIV‐2 in Native Spanish Individuals

    Vox Sanguinis

  2. HTLV-I infection in Spain. Analysis of 24 cases identified until November, 1994. Spanish Group for the Study of HTLV-I/II)

    Medicina clínica, Vol. 105, Núm. 7, pp. 246-250

  3. HTLV‐I‐Associated Illnesses in Spain

    Vox Sanguinis

  4. Type 2 human immunodeficiency virus infection (HIV-2) in Spain: analysis of the first 50 cases. Spanish Group for the Study of HIV-2

    Medicina clínica, Vol. 105, Núm. 7, pp. 241-245

1993

  1. A multicenter study of infection with human immunodeficiency virus type-2 (HIV-2) in Spain (1991). The Spanish Group for the Study of HIV-2

    Medicina clínica, Vol. 100, Núm. 14, pp. 531-535

  2. Evaluation of various criteria for the interpretation of western blot for the diagnosis of human immunodeficiency virus infection. Spanish Group for the Study of HIV-2

    Medicina clínica, Vol. 100, Núm. 15, pp. 561-566